Back to Search
Start Over
Corneal Collagen Cross-Linking in Pellucid Marginal Degeneration: 2 Patients, 4 Eyes.
- Source :
-
Case Reports in Ophthalmological Medicine . 5/11/2015, Vol. 2015, p1-4. 4p. - Publication Year :
- 2015
-
Abstract
- Purpose. To report the long-term results of corneal collagen cross-linking (CXL) with riboflavin and ultraviolet-A irradiation in 4 eyes of 2 patients affected by pellucid marginal degeneration (PMD). Methods. This study involved the retrospective analysis of 4 eyes of 2 patients with PMD that underwent CXL treatment. Of the eyes, three had only CXL treatment and one had CXL treatment after an intrastromal corneal ring segment implantation. We have pre- and postoperatively evaluated uncorrected distance visual acuity (UDVA), best corrected distance visual acuity (BCDVA), corneal topography (Pentacam), specular microscopy, and pachymetry. Results. Patient 1 was a woman, aged 35, and Patient 2 was a man, aged 33. The right eye of Patient 1 showed an improvement in her BCDVA, from 16/40 to 18/20 in 15 months, and her left eye improved from 12/20 to 18/20 in 20 months. Patient 2’s right eye showed an improvement in his BCDVA, from 18/20 to 20/20 in 43 months, and his left eye improved from 16/20 to 18/20 in 22 months. No complications were recorded during or after the treatment. Conclusion. CXL is a safe tool for the management of PMD, and it can help to stop the progression of this disease. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 20906722
- Volume :
- 2015
- Database :
- Academic Search Index
- Journal :
- Case Reports in Ophthalmological Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 109225157
- Full Text :
- https://doi.org/10.1155/2015/840687